Burger King ® Japan Announces the Japan-exclusive Release of the World-shocking Burger, the "Kyoto Whopper ® "!
BK Japan Holdings Co., Ltd. (Headquarters: Chiyoda-ku, Tokyo; President: Kazuhiro Nomura) will release a limited-time Japan-exclusive burger, the "KYOTO Whopper®," starting Friday, November 1, 2024. This unique burger was co-developed with Kyoto’s renowned rice vendor, Hachidaime Gihey Co., Ltd. (Headquarters: Shimogyo-ku, Kyoto; President: Gihey Hashimoto). The burger features a specially crafted rice patty and 100% flame-grilled beef patty, topped with a “special Japanese-style ginger sauce” consisting of “dashi soy sauce” infused with the umami of four types of dashi, and enhanced with four Japanese spices.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241030411532/en/
KYOTO Whopper (Graphic: Business Wire)
“KYOTO Whopper®” special site URL: https://app.burgerking.co.jp/bkad/kyotowhopper/index.html
The collaboration between Burger King® Japan and Kyoto’s long-established rice vendor, Hachidaime Gihey, has led to the creation of the “KYOTO Whopper®”—a burger that will astonish the world. This unique burger combines a flame-grilled 100% beef patty with a newly innovated “special rice patty,” embodying the commitment to tradition, flavor, and expert craftsmanship from both parties.
The “KYOTO Whopper®” features a flame-grilled 100% beef patty topped with a newly innovated “special rice patty,” made from a blend of 2024 harvested white rice and Kin no Ibuki (brown rice) just for the “KYOTO Whopper®”, along with fresh lettuce, tomato, and onion. It is finished with a “special Japanese-style ginger sauce” consisting of “dashi soy sauce” which holds the rich umami of four types of dashi (bonito, mackerel shavings, shiitake mushrooms, and kelp) and infused with four traditional Japanese spices (roasted chili pepper, Japanese pepper, ginger, and dried citrus peel.) This burger brings together tradition, flavor, and expert craftsmanship, allowing you to fully enjoy the delicious combination of meat and rice.
We invite everyone in Japan, as well as visitors from around the world, to experience the “KYOTO Whopper®”—a Japan-exclusive burger created through the collaboration between Burger King® Japan and Kyoto’s renowned rice vendor, Hachidaime Gihey. This burger is sure to amaze people worldwide!
Product overview
Product Name: KYOTO Whopper®
Release Date: Friday, November 1, 2024
Price: ¥990 À la carte, ¥1,290 Meal
*Only available in Burger King restaurants in Japan.
About BURGER KING®
Founded in 1954, the Burger King® brand is a global fast-food hamburger chain known for food quality and value as the only place guests can get the iconic flame-grilled Whopper® sandwich. The Burger King system operates more than 19,000 locations in more than 100 countries. Almost 100 percent of Burger King restaurants are owned and operated by independent franchisees, many of them family-owned operations that have been in business for decades. Burger King is a subsidiary of Restaurant Brands International Inc. ("RBI"), one of the world's largest quick service restaurant companies with over $40 billion in annual system-wide sales and over 30,000 restaurants in more than 100 countries. RBI owns four of the world's most prominent and iconic quick service restaurant brands – BURGER KING®, TIM HORTONS®, POPEYES®, and FIREHOUSE SUBS®.
In Japan, BK Japan Holdings is in charge of domestic marketing and store management, handling operations such as new franchisee training, menu development, and sales strategy, as well as store development and new restaurant openings.
BK Japan Holdings company overview
BK Japan Holdings
Address: Kyodo Building Ichibancho 3F, 16-1 Ichibancho, Chiyoda-ku, Tokyo
URL: https://www.burgerking.co.jp
View source version on businesswire.com: https://www.businesswire.com/news/home/20241030411532/en/
Contacts
Press inquiries:
Burger King® Japan PR Executive Office (ANTIL Inc. internal)
Staff in charge: Omori, Kawashima, Nishida
E-mail: burgerking@vectorinc.co.jp
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Xsolla and Long Tale Games Launch Charity Campaign With Life Is Feudal to Support Games for Change31.10.2024 15:00:00 EET | Press release
Xsolla, a global video game commerce company, has partnered with Long Tale Games to launch a charity campaign. 50% of the proceeds from the 3-month subscription package to Life is Feudal will be donatedto Games For Change. This initiative, running until December 31st, reflects Xsolla’s commitment to leveraging the power of gaming to drive positive change. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241031878088/en/ (Graphic: Xsolla) The campaign offers players an exciting adventure in Life is Feudal: MMO and allows them to make a tangible impact. With half of each 3-month subscription supporting educational programs, civic engagement initiatives, and social impact projects, the campaign demonstrates how gaming can foster a better future through the power of play. Players are empowered to engage with a meaningful cause, proving that games are more than just entertainment—they are a way to support causes that matter. "Gamin
Medidata Launches Bundled Solutions to Support Oncology and Vaccine Trials, Accelerating Study Design and Execution31.10.2024 14:00:00 EET | Press release
Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, has introduced two new bundled offerings to meet the growing demands of oncology and vaccine research. Medidata Oncology Solutions and Medidata Vaccine Solutions reinforce the FDA guidance for patient-centered endpoints, adaptive trial designs, and trial diversity. By unifying key trial components such as real-time patient-reported outcomes and imaging management, these bundled solutions will aid sponsors by reducing trial complexity, accelerating decision-making, and improving assessments of treatment efficacy and safety. "Oncology and vaccine trials face significant challenges in recruiting diverse patients, ensuring rapid execution, and maintaining and monitoring patient safety," said Joseph Schmidt, chief operating officer, Medidata. "By making these new bundled capabilities readily available to customers, we can deliver a solution built on Medidata’s vast experience
Hassana Investment Company and EIG Sign MoU for Strategic Collaboration on Middle East Infrastructure and Energy Transition Projects31.10.2024 14:00:00 EET | Press release
Hassana Investment Company (Hassana) and EIG, a leading institutional investor to the global energy and infrastructure sectors, have signed a memorandum of understanding (MoU) to collaborate on infrastructure and energy transition projects in the Middle East through EIG’s targeted US$1 billion dedicated regional fund in which Hassana is considering becoming an anchor investor with an allocation of up to US$250 million. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241029142798/en/ (Photo: Business Wire) The MoU underscores EIG’s and Hassana’s shared commitment to expand their local and regional infrastructure and energy transition investment portfolios. By fostering participation from international investors and boosting foreign direct investment, this partnership aims to support the Kingdom of Saudi Arabia’s Vision 2030 goals and the broader regional shift toward cleaner, sustainable energy solutions. The MoU was signed by
Kinaxis Announces Normal Course Issuer Bid31.10.2024 13:00:00 EET | Press release
Kinaxis® Inc. (“Kinaxis” or the “Company”) (TSX: KXS) is pleased to announce that the Toronto Stock Exchange (the “Exchange” or “TSX”) has accepted a notice (the “Notice”) filed by the Company of its intention to make a normal course issuer bid (the “NCIB”). In connection with the NCIB, the Company has entered into an automatic share purchase plan (an “ASPP”) with its designated broker to allow for purchases of its common shares (the “Shares”). The Notice provides that the Company may, during the 12-month period commencing November 6, 2024 and ending November 5, 2025, or on such earlier date as Kinaxis completes its purchases or provides notice of termination, purchase up to 1,404,639 Shares in total, representing approximately 5% of the issued and outstanding Shares as at October 23, 2024. As of the close of business on October 23, 2024, the Company had 28,092,786 Shares issued and outstanding. Except for block purchases permitted under the rules of the TSX, the number of Shares to be
Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates31.10.2024 12:30:00 EET | Press release
Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating access to evidence-based innovation in mental health, today reported its financial results for the third quarter 2024 and an update on recent business progress. “Ensuring the success of our lead COMP360 program is our absolute priority. We remain confident that COMP360 can be an effective therapy for patients with serious mental illness and our focus on delivering new treatment options for patients living with treatment-resistant depression remains paramount,” said Kabir Nath, Chief Executive Officer of Compass Pathways. “The shift in the phase 3 pivotal program timeline has forced us to look carefully at our operations and ensure that every resource is focused on this goal. As such, we have made the difficult decision to reduce our workforce and exit activities that are not directly tied to the completion of the trials, regulatory filing and commercialization if approved. These are neces
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom